...
首页> 外文期刊>Die Pharmazie >Development and characterization of bicalutamide-poloxamer F68 solid dispersion systems.
【24h】

Development and characterization of bicalutamide-poloxamer F68 solid dispersion systems.

机译:比卡鲁胺-泊洛沙姆F68固体分散体系的开发和表征。

获取原文
获取原文并翻译 | 示例
           

摘要

The objective of the present work was to improve the dissolution rate of a poorly water-soluble drug, bicalutamide, by a solid dispersion technique. The solid dispersion systems of bicalutamide were prepared with poloxamer F68 in 1:1, 1:3, and 1:5 ratios using the melting method. The interaction of drug with polymer was evaluated by TLC, FTIR, and powder XRD. The results of powder XRD showed a significant decrease in the crystallinity of drug in the binary systems of bicalutamide. All binary systems of bicalutamide showed faster dissolution than pure drug alone (p < 0.001). However, among all binary systems studied, 1:1 proportion of bicalutamide : poloxamer was found to be excellent for dissolution enhancement (DP30: 99.98% +/- 3.9) of bicalutamide. The higher ratios of poloxamer F68 (1:3 and 1:5) had retarded the release of drug from their corresponding binary systems which might be due to its gelling property in higher concentration.
机译:本工作的目的是通过固体分散技术提高水溶性差的药物比卡鲁胺的溶解速度。使用熔化法,以1:1、1:3和1:5的泊洛沙姆F68制备比卡鲁胺的固体分散体系。通过TLC,FTIR和粉末XRD评估了药物与聚合物的相互作用。粉末XRD结果表明,在比卡鲁胺的二元体系中,药物的结晶度显着降低。比卡鲁胺的所有二元系统均显示出比单纯纯药物更快的溶出度(p <0.001)。但是,在所有研究的二元体系中,发现比卡鲁胺:泊洛沙姆的比例为1:1时,对比卡鲁胺的溶解度提高(DP30:99.98 +/- 3.9)极好。泊洛沙姆F68的较高比例(1:3和1:5)阻碍了药物从其相应的二元系统释放,这可能是由于其在较高浓度下的胶凝特性所致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号